Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide

Bibliographic Details
Title: Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide
Authors: Shanna J. Smith, Caroline M. Li, Robert G. Lingeman, Robert J. Hickey, Yilun Liu, Linda H. Malkas, Mustafa Raoof
Source: Molecular Therapy: Oncolytics, Vol 17, Iss , Pp 250-256 (2020)
Publisher Information: Elsevier, 2020.
Publication Year: 2020
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Pancreatic Cancer, PCNA, DNA repair, Cell-penetrating peptide, DNA damage, Replication Stress, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Pancreatic ductal adenocarcinoma is a particularly difficult cancer to treat due to a lack of effective screening or treatment. Pancreatic cancer cells exhibit high proliferating cell nuclear antigen (PCNA) expression, which is associated with poor prognosis. PCNA, an important nuclear DNA replication and repair protein, regulates a myriad of proteins via the interdomain connector loop. Within this region, amino acids 126–133 are critical for PCNA interactions in cancer cells. Here, we investigate the ability of a decoy cell-penetrating peptide, R9-caPeptide, that mimics the interdomain connector loop region of PCNA to disrupt PCNA-protein interactions in pancreatic cancer cells. Our data suggest that R9-caPeptide causes dose-dependent toxicity in a panel of pancreatic cancer cell lines by inhibiting DNA replication fork progression and PCNA-regulated DNA repair, ultimately causing lethal DNA damage. Overall, these studies lay the foundation for novel therapeutic strategies that target PCNA in pancreatic cancer.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2372-7705
Relation: http://www.sciencedirect.com/science/article/pii/S2372770520300504; https://doaj.org/toc/2372-7705
DOI: 10.1016/j.omto.2020.03.025
Access URL: https://doaj.org/article/a1ad7611a80949079f0a82b199712e39
Accession Number: edsdoj.1ad7611a80949079f0a82b199712e39
Database: Directory of Open Access Journals
More Details
ISSN:23727705
DOI:10.1016/j.omto.2020.03.025
Published in:Molecular Therapy: Oncolytics
Language:English